A Critical Analysis of Clinical Outcomes Reported in Stem Cell Trials for Acute Myocardial Infarction: Some Thoughts for Design of Future Trials-Reference-Cited by-同舟云学术

A Critical Analysis of Clinical Outcomes Reported in Stem Cell Trials for Acute Myocardial Infarction: Some Thoughts for Design of Future Trials

Published:2013-06-21 Issue:8 Volume:15 Page:
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Szady Anita D., ,Pepine Carl J.,Sharma Shreela V.,Cogle Christopher R.,Perin Emerson C.,Ellis Stephen G.,Moyé Lemuel A.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11883-013-0341-9.pdf

Reference29 articles.

1. Assmus B, Leistner D, Fischer-Rasokat U, et al. Abstract 1984: 5 years follow-up indicate safety and sustained improvement of cardiac function in the TOPCARE-AMI trial. Circulation. 2008;118(Suppl:S):400–1.

2. • Assmus B, Rolf A, Erbs S, et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail. 2010;3:89–96. Randomized controlled trial of injection of stem cells after acute myocardial infarction.

3. Assmus B, Schächinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009–17.

4. Beitnes JO, Gjesdal O, Lunde K, et al. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study. Eur J Echocardiogr. 2011;12:98–106.

5. • Beitnes JO, Hopp E, Lunde K, et al. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart. 2009;95:1983–9. Randomized controlled trial of injection of stem cells after acute myocardial infarction.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cells in Cardiovascular Diseases: 30,000-Foot View;Cells;2021-03-09

2. Mind the Gap: Current Challenges and Future State of Heart Failure Care;Canadian Journal of Cardiology;2017-11

3. Stem Cell Therapy for Acute Myocardial Infarction;Stem Cell and Gene Therapy for Cardiovascular Disease;2016

4. VEGF165Amicrosphere therapy for myocardial infarction suppresses acute cytokine release and increases microvascular density but does not improve cardiac function;American Journal of Physiology-Heart and Circulatory Physiology;2015-08-01

5. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial);European Heart Journal;2015-04-29